Elevai Labs forms Scientific Advisory Board for weight loss programs

Elevai Labs announced the formation of a new Scientific Advisory Board to support the advancement of EL-22, a first-in-class engineered probiotic approach, to address obesity’s pressing issue of preserving muscle while on weight loss treatments, including GLP-1 receptor agonists. The members of Elevai’s new Scientific Advisory Board include: Roger A. Fielding, PhD serves as Team Lead and Senior Scientist of the Nutrition, Exercise Physiology, and Sarcopenia Team at the Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University. He is also Professor of Nutrition at Tufts’ Friedman School of Nutrition Science and Policy, Professor of Medicine at Tufts University School of Medicine and the Associate Director of the Boston Claude D. Pepper Older Americans Independence Center. Eduardo Grunvald, MD, is a board-certified obesity medicine physician. As Director of the Weight Management Program of the University of California San Diego, Dr. Grunvald evaluates and manages patients through their health- and weight-loss journeys and has extensive experience using medications for weight management. Elevai expects to be recruiting additional distinguished scientific leaders with vast experience in the metabolic and obesity field to join its the Scientific Advisory Board.